One or two intact local summaries. No averaged regimen, patient-specific dose or automatic source preference.
1 local source card selected. Local card fingerprints checked where supplied. This is not an original-document hash, source-currency guarantee or clinical approval. Record-level cautions below are the current library's cautions, not a frozen prior version.
Independent clinical review is pending. Confirm indication, exact formulation/route, population, renal measure and units, kidney-function stability, dialysis prescription, interacting drugs, monitoring and source revision. An RX mirror and its original label are not independent corroboration. Missing disagreement notes do not certify agreement.
| eGFR | Oral dose |
|---|---|
| 60 to below 90 | 2 mg once daily |
| 30 to below 60 | 1 mg once daily |
| Below 30 | Not recommended |
RDM32-baricitinib-olumiant-1 · Source locator: 2.6, Table 3; 8.7
At eGFR 30 to below 60, reduce a 2 mg daily regimen to 1 mg daily, or a 4 mg daily regimen to 2 mg daily. Below 30, use is not recommended.
RDM32-baricitinib-olumiant-2 · Source locator: 2.6, Table 4; 8.7
| eGFR | Oral dose |
|---|---|
| 60 to below 90 | 4 mg once daily |
| 30 to below 60 | 2 mg once daily |
| 15 to below 30 | 1 mg once daily |
| Below 15, dialysis, end-stage disease or acute kidney injury | Not recommended |
Review the separate indication, treatment-duration and drug-interaction instructions.
RDM32-baricitinib-olumiant-3 · Source locator: 2.6, Table 5; 8.7
Selected renal sections only, not a complete monograph. Exact product, indication, patient population, renal method and all other contraindications/interactions remain controlling.
Second independent renal reference and clinician adjudication remain pending; no all-indication, dialysis or pediatric dose may be inferred from an omitted field.
This reference does not select a regimen. Complete the indication, measured/estimated renal function and trend, dialysis setting, source rationale, monitoring and reassessment plan in your institution's approved documentation system. Confirm the complete current source before adopting its regimen.
Pinned reference: https://globalrph.com/blogCalcs/renal-dosing-master/compare.php?id=baricitinib-olumiant&s1=RDM32-label-baricitinib-olumiant&h1=a5c61b04c3d1cb0d073cf4ca9a12903fe406ae599515c8221aa991100b49a6f3